Search results
AbbVie | Pharmaceutical Research & Development. Inventing the Future of Medicine. By investing in groundbreaking technologies, we’re on a mission to deliver better solutions to patients. Learn more. Pipeline. Advancing medicines with strong clinical performance in areas of great need. Focus Areas.
We are committed to: Improve health outcomes by advancing patient health and wellbeing through our focus on innovation. Operate responsibly by fostering an ethical, transparent and inclusive culture that drives sustainable growth. Contribute to society using our unique capabilities to help address the challenges of the underserved. 400+.
Improving lives. Whether you work in the lab, in an office or on the production floor, the objective is the same. We offer development opportunities that provide you the chances to innovate, collaborate and demonstrate your passion for patients and excellence. Search All Jobs. Join Our Talent Community. Meet the People. Share the Passion.
Jan 25, 2024 · This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network. Located in Singapore's Tuas Biomedical Park, AbbVie's Singapore plant is a state-of-the-art small-molecule and biologics manufacturing facility serving markets worldwide.
Jan 26, 2024 · New York-listed AbbVie strengthened its manufacturing capabilities by breaking ground on a new $223 million expansion of its Singapore manufacturing facility. This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie’s global network.
Jan 26, 2024 · Thursday, AbbVie broke ground on a $223 million expansion of its Singapore manufacturing facility. The project is expected to create more than 100 new jobs and bolster AbbVie's global...
Apr 13, 2021 · Established in 2013, biopharmaceutical giant AbbVie's high-performing culture has been reflected in a strong financial track record, and quick expansion over a short amount of time.
Sep 28, 2016 · AbbVie Opens First Phase of its Global Manufacturing Facility in Singapore to Support the Growth of its Pipeline. - New site to expand the company's global operations for small molecule and biologics manufacturing. - Marks AbbVie's first manufacturing presence in Asia.
Jan 31, 2024 · AbbVie has announced a significant investment of $223 million in a new biologics manufacturing facility in Singapore. The expansion will add more than 100 jobs and new biologics manufacturing capacity to AbbVie’s global network. The construction will commence immediately with facilities becoming operational in 2026.
Jan 30, 2024 · Pharmaceutical company AbbVie has initiated a significant expansion of its Singapore manufacturing facility, investing US$223 million (S$301 million) in the project. The company announced this expansion during a groundbreaking ceremony on January 25.
